Screening of Recurrence Related MicroRNA in Ductal Carcinoma In Situ and Functional Study of MicroRNA-654-5p

PURPOSE: Ductal carcinoma in situ (DCIS) contributes to 20%–30% of newly diagnosed cases of breast cancer in China. Although the breast cancer-specific mortality of DCIS is extremely low, a small proportion of DCIS patients still show relapse or metastasis, leading to poor prognosis. Little is known...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shi, Pu, Tianjie, Xiao, Lin, Gao, Hongwei, Li, Li, Ye, Feng, Liu, Yueping, Bu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438835/
https://www.ncbi.nlm.nih.gov/pubmed/30941233
http://dx.doi.org/10.4048/jbc.2019.22.e4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438835/
https://www.ncbi.nlm.nih.gov/pubmed/30941233
http://dx.doi.org/10.4048/jbc.2019.22.e4

Ejemplares similares